𝔖 Bobbio Scriptorium

✦ LIBER ✦

Randomised trial of addition of lamivudine or lamivudine plus loviride to zidovudine-containing regimens for patients with HIV-1 infection: the CAESAR trial

Book ID: 118562302
Publisher: The Lancet
Year: 1997
Tongue: English
Weight: 72 KB
Volume: 349
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(97)04441-3

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of three short-course regimens

Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa, and Uganda (Petra study): a randomised, double-blind, placebo-controlled trial

📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 118 KB

Dual therapy with lopinavir and ritonavi

Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the randomised, open label, non-inferiority GARDEL trial

✍ Cahn, Pedro; Andrade-Villanueva, Jaime; Arribas, José R; Gatell, José M; Lama, J 📂 Article 📅 2014 🏛 The Lancet 🌐 English ⚖ 321 KB

Durable efficacy of tipranavir-ritonavir

Durable efficacy of tipranavir-ritonavir in combination with an optimised background regimen of antiretroviral drugs for treatment-experienced HIV-1-infected patients at 48 weeks in the Randomized Evaluation of Strategic Intervention in multi-drug reSistant patients with Tipranavir (RESIST) studies: an analysis of combined data from two randomised open-label trials

✍ Charles B Hicks; Pedro Cahn; David A Cooper; Sharon L Walmsley; Christine Katlam 📂 Article 📅 2006 🏛 The Lancet 🌐 English ⚖ 124 KB